Comparative analysis of binary and ternary cyclodextrin complexes with econazole nitrate in solution and in solid state

Journal of Pharmaceutical and Biomedical Analysis

Volumn 91, Issue , 2014, Pages 81-91

  Jug, Mario ^a   Mennini, Natascia ^b   Kövér, Katalin E ^c   Mura, Paola ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Co grinding; Cyclodextrins; Econazole nitrate; Solidstate analysis

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; AMINO ACID; BETA CYCLODEXTRIN DERIVATIVE; BETA CYCLODEXTRIN SULFOBUTYL ETHER; CITRIC ACID; CYCLODEXTRIN; ECONAZOLE; HYDROXYETHYL BETA CYCLODEXTRIN; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; COMPARATIVE STUDY; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG POTENTIATION; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOLECULAR WEIGHT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SALIVA; SOLID STATE; SOLUBILITY; STOICHIOMETRY; THRUSH; X RAY POWDER DIFFRACTION;

(1)H NMR; CO-GRINDING; CYCLODEXTRINS; ECONAZOLE NITRATE; SOLIDSTATE ANALYSIS;

BETA-CYCLODEXTRINS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; ECONAZOLE; PHARMACEUTICAL SOLUTIONS; POWDERS; SOLUBILITY; X-RAY DIFFRACTION;

EID: 84892663072     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2013.12.029     Document Type: Article

References (42)

1. de Freitas E.M., Nobre S.A., de Oliveira Pires M.B., Faria R.V., Batista A.U., Bonan P.R. Oral Candida species in head and neck cancer patients treated by radiotherapy. Auris Nasus Larynx 2013, 40:400-404.
2. Ellepola A.N.B., Samaranayake L.P. Inhalation and topical steroids, and oral candidosis: a mini review. Oral Dis. 2001, 7:211-216.
3. Williams D., Lewis M. Pathogenesis and treatment of oral candidosis. J. Oral Microbiol. 2014, 10.3402/jom.v3i0.5771.
4. Ellepola A.N.B., Samaranayake L.P. Oral Candidal infections and antimycotics. Crit. Rev. Oral Biol. Med. 2000, 11:172-198.
5. Llabot J.M., Palma S.D., Manzo R.H., Allemandi D.A. Design of novel antifungal mucoadhesive films. Part I. Pre-formulation studies. Int. J. Pharm. 2007, 330:54-60.
6. The Extra Pharmacopoeia 2009, 531. Royal Pharm. Soc., Pharmaceutical Press, London. 36th edition. S.C. Sweetman (Ed.).
7. Muller K., Figueroa C., Martinez C., Medel M., Obreque E., Pena-Neira A., Morales-Bozo I., Toledo H., Lopez-Solis R.O. Measurement of saliva volume in the mouth of members of a trained sensory panel using a beetroot (Beta vulgaris) extract. Food Qual. Prefer. 2010, 21:569-574.
8. Fouda M.M.G., Knittel D., Hippler U.C., Elsner P., Schollmeyer E. Antimycotic influence of beta-cyclodextrin complexes - in vitro measurements using laser nephelometry in microtiter plates. Int. J. Pharm. 2006, 311:113-121.
9. Jacobsen J., Bjerregaard S., Pedersen M. Cyclodextrin inclusion complexes of antimycotics intended to act in the oral cavity - drug supersaturation, toxicity on TR146 cells and release from a delivery system. Eur. J. Pharm. Biopharm. 1999, 48:217-224.
10. Pedersen M., Bjerregaard S., Jacobsen J., Larsen A.R., Sorensen A.M. An econazole beta-cyclodextrin inclusion complex: an unusual dissolution rate, supersaturation, and biological efficacy example. Int. J. Pharm. 1998, 165:57-68.
11. Mura P., Faucci M.T., Manderioli A., Bramanti G. Multicomponent systems of econazole with hydroxyacids and cyclodextrins. J. Incl. Phenom. Macrocycl. Chem. 2001, 39:131-138.
12. 1H NMR and molecular modelling techniques for the investigation of the inclusion complex of econazol with α-cyclodextrin in the presence of malic acid. J. Pharm. Biomed. Anal. 2000, 23:25-31.
13. Loftsson T., Duchene D. Cyclodextrins and their pharmaceutical applications. Int. J. Pharm. 2007, 329:1-11.
14. Ogawa N., Higashi K., Nagase H., Endo T., Moribe K., Loftsson T., Yamamoto K., Ueda H. Effects of cogrinding with β-cyclodextrin on the solid state of fentanyl. J. Pharm. Sci. 2010, 99:5019-5029.
15. Aigner Z., Berkesi O., Farkas G., Szabó-Révész P. DSC, X-ray, FTIR studies of a gemfibrozil/dimethyl-β-cyclodextrin inclusion complex produced by co-grinding. J. Pharm. Biomed. Anal. 2012, 57:62-67.
16. Jablan J., Bačić I., Kujundžić N., Jug M. Zaleplon co-ground complexes with natural and polymeric β-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 2013, 76:353-362.
17. Colombo I., Grassi G., Grassi M. Drug mechanochemical activation. J. Pharm. Sci. 2009, 98:3961-3986.
18. Higuchi T., Connors K.A. Phase solubility techniques. Adv. Chem. Instrum. 1965, 4:117-212.
19. Azarmi S., Roa W., Löbenberg R. Current perspectives in dissolution testing of conventional and novel dosage forms. Int. J. Pharm. 2007, 328:12-21.
20. Anderson N.H., Bauer M., Boussac N., Khan-Malek R., Munden P., Sardaro M. An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles. J. Pharm. Biomed. Anal. 1998, 17:811-822.
21. Mura P., Faucci M.T., Maestrelli F., Furlanetto S., Pinzauti S. Characterization of physicochemical properties of naproxen systems with amorphous β-cyclodextrin-epichlorohydrin polymers. J. Pharm. Biomed. Anal. 2002, 29:1015-1024.
22. Jug M., Mennini N., Melani F., Maestrelli F., Mura P. Phase solubility, 1H NMR and molecular modelling studies of bupivacaine hydrochloride complexation with different cyclodextrin derivatives. Chem. Phys. Lett. 2010, 500:347-354.
23. Jug M., Kosalec I., Maestrelli F., Mura P. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative. J. Pharm. Biomed. Anal. 2011, 54:1030-1039.
24. Layre A.M., Gosselet N.M., Renard E., Sebille B., Amiel C. Comparison of the complexation of cosmetical and pharmaceutical compounds with γ-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin and water soluble β-cyclodextrin-co-epichlorohydrin polymers. J. Incl. Phenom. Macrocycl. Chem. 2002, 43:311-317.
25. Challa R., Ahuja A., Javed A., Khar R.K. Cyclodextrins in drug delivery: an updated review. AAPS Pharm. Sci. Technol. 2005, 6:329-357.
26. Zia V., Rajewski R.A., Stella V.J. Effect of cyclodextrin charge on complexation of neutral and charged substrates: comparison of (SBE)7M-beta-CD to HP-beta-CD. Pharm. Res. 2001, 18:667-673.
27. Loftsson T., Brewster M.E. Cyclodextrins as functional excipients: methods to enhance complexation efficiency. J. Pharm. Sci. 2012, 101:3019-3032.
28. Mura P., Faucci M.T., Manderioli A., Bramanti G. Multicomponent complexes of econazole with hydroxyacids and cyclodextrins. J. Incl. Phenom. Macrocycl. Chem. 2001, 39:131-138.
29. Kurkov S.V., Loftsson T., Cyclodextrins Int. J. Pharm. 2013, 453:167-180.
30. Schneider H.-J., Hacket F., Rudiger V., Ikeda H. NMR studies of cyclodextrins and cyclodextrin complexes. Chem. Rev. 1998, 98:1755-1785.
31. Spamer E., Muller D.G., Wessels P.L., Venter O.P. Characterization of the complexes of furosemide with 2-hydroxypropyl-β-cyclodextrin and sulfobutyl ether-7-β-cyclodextrin. Eur. J. Pharmacol. 2002, 16:247-253.
32. Xiao Y., Ng S.-C., Tan T.T.Y., Wanga Y. Recent development of cyclodextrin chiral stationary phases and their applications in chromatography. J. Chromatogr. A 2012, 1269:52-68.
33. Redondo J., Capdevila A., Latorre I., Bertran J. Host-guest complexation of omeprazole, pantoprazole and rabeprazole sodium salts with cyclodextrins: an NMR study on solution structures and enantiodiscrimination power. J. Incl. Phenom. Macrocycl. Chem. 2012, 73:225-236.
34. Djedaine F., Lin S., Perly B., Wouessidjewe D. High-field nuclear magnetic resonance techniques for the investigation of a β-cyclodextrin:indomethacin inclusion complex. J. Pharm. Sci. 1990, 79:643-646.
35. Ribeiro L., Carvalho R.A., Ferreira D.C., Veiga F.J.B. Multicomponent complex formation between vinpocetine, cyclodextrins, tartaric acid and water-soluble polymers monitored by NMR and solubility studies. Eur. J. Pharmacol. 2005, 24:1-13.
36. Jug M., Maestrelli F., Bragagni M., Mura P. Preparation and solid-state characterization of bupivacaine hydrochloride complexes aimed for buccal delivery. J. Pharm. Biomed. Anal. 2010, 52:9-18.
37. Figueiras A., Sarraguca J.M.G., Carvalho R.A., Pais A.A.C.C., Veiga F.J.B. Interaction of omeprazole with a methylated derivative of β-cyclodextrin: phase solubility, NMR spectroscopy and molecular simulation. Pharm. Res. 2007, 24:377-389.
38. Liu W., Zhao B., Li Y.-C., Liu H.-M. NMR spectra and structures of oridonin derivatives complexes with β-cyclodextrin. Magn. Reson. Chem. 2011, 49:611-615.
39. Mártha C., Kürti L., Farkas G., Jójárt-Laczkovich O., Szalontai B., Glässer E., Deli M.A., Szabó-Révész P. Effects of polymers on the crystallinity of nanonized meloxicam during a co-grinding process. Eur. Polym. J. 2014, 10.1016/j.eurpolymj.2013.03.006.
40. Aigner Z., Hassan H.B., Berkesi O., Kata M., Eros I. Thermoanalytical, FTIR and X-ray studies of gemfibrozil-cyclodextrin complexes. J. Therm. Anal. Calorim. 2005, 81:267-272.
41. Jablan J., Szalontai G., Jug M. Comparative analysis of zaleplon complexation with cyclodextrins and hydrophilic polymers in solution and in solid state. J. Pharm. Biomed. Anal. 2012, 71:35-44.
42. Loftsson T., Vogensen S.B., Brewster M.E., Konradsdottir F. Effects of cyclodextrins on drug delivery through biological membranes. J. Pharm. Sci. 2007, 96:2532-2546.